Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.6B |
| 2 |
Broadcom
AVGO
|
+$1.11B |
| 3 |
Invesco QQQ Trust
QQQ
|
+$882M |
| 4 |
JPMorgan Chase
JPM
|
+$628M |
| 5 |
Tesla
TSLA
|
+$594M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Honeywell
HON
|
+$1.54B |
| 2 |
Visa
V
|
+$1.39B |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.13B |
| 4 |
Amazon
AMZN
|
+$771M |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$575M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 45.6% |
| 2 | Technology | 19.83% |
| 3 | Financials | 7.37% |
| 4 | Consumer Discretionary | 6.6% |
| 5 | Communication Services | 5.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2726
FerroAtlántica
GSM
$796M
| $2.25M | ﹤0.01% |
612,015
-536,482
| -47% | -$1.97M |
2025 Q1
1 quarter
|
|
2727
Castle Biosciences
CSTL
$1.09B
| $2.24M | ﹤0.01% |
109,743
+66,928
| +156% | +$1.24M |
2022 Q1
13 quarters
|
|
2728
Cellebrite
CLBT
$2.78B
| $2.24M | ﹤0.01% |
140,037
-13,987
| -9% | -$249K |
2023 Q2
8 quarters
|
|
|
EFC
2729
Ellington Financial
EFC
$1.49B
| $2.24M | ﹤0.01% |
172,413
+61,212
| +55% | +$778K |
2022 Q1
13 quarters
|
|
|
ORLA
2730
DELISTED
Orla Mining
ORLA
| $2.24M | ﹤0.01% |
223,284
-29,070
| -12% | -$302K |
2021 Q1
17 quarters
|
|
2731
Clover Health Investments
CLOV
$2.33B
| $2.23M | ﹤0.01% |
800,674
+354,520
| +79% | +$1.17M |
2024 Q3
3 quarters
|
|
2732
CALL
Coherent
COHR
$66B
| $2.23M | ﹤0.01% |
+25,000
| New | +$1.8M |
2025 Q2
0 quarters
|
|
|
SEI
2733
Solaris Energy Infrastructure
SEI
$4.93B
| $2.22M | ﹤0.01% |
78,620
+3,943
| +5% | +$92.8K |
2019 Q1
25 quarters
|
|
2734
Intuitive Machines
LUNR
$2.37B
| $2.22M | ﹤0.01% |
204,282
+118,233
| +137% | +$1.16M |
2024 Q2
4 quarters
|
|
2735
Janus International
JBI
$574M
| $2.22M | ﹤0.01% |
272,780
+85,271
| +45% | +$650K |
2022 Q1
13 quarters
|
|
2736
AnaptysBio
ANAB
$1.45B
| $2.22M | ﹤0.01% |
99,999
+43,780
| +78% | +$916K |
2017 Q1
33 quarters
|
|
2737
Astec Industries
ASTE
$967M
| $2.22M | ﹤0.01% |
53,198
+14,066
| +36% | +$534K |
2013 Q2
48 quarters
|
|
2738
ImmunityBio
IBRX
$10.9B
| $2.22M | ﹤0.01% |
839,894
+474,859
| +130% | +$1.28M |
2022 Q1
13 quarters
|
|
2739
Under Armour
UAA
$2.02B
| $2.21M | ﹤0.01% |
323,748
-769,782
| -70% | -$4.79M |
2013 Q2
48 quarters
|
|
2740
BJ's Restaurants
BJRI
$1.32B
| $2.21M | ﹤0.01% |
49,499
+18,922
| +62% | +$747K |
2013 Q2
48 quarters
|
|
2741
CALL
CleanSpark
CLSK
$3.27B
| $2.21M | ﹤0.01% |
+200,000
| New | +$1.78M |
2025 Q2
0 quarters
|
|
2742
Radware
RDWR
$1.29B
| $2.2M | ﹤0.01% |
74,733
-834
| -1% | -$19.7K |
2014 Q3
43 quarters
|
|
2743
Safety Insurance
SAFT
$1.53B
| $2.2M | ﹤0.01% |
27,707
+9,104
| +49% | +$719K |
2016 Q1
37 quarters
|
|
2744
PUT
Sable Offshore Corp
SOC
$673M
| $2.2M | ﹤0.01% |
+100,000
| New | +$2.33M |
2025 Q2
0 quarters
|
|
|
APO.PRA
2745
DELISTED
Apollo Global Management Series A
APO.PRA
| $2.2M | ﹤0.01% |
29,337
-47,329
| -62% | -$3.35M |
2023 Q4
6 quarters
|
|
2746
Helios Technologies
HLIO
$2.36B
| $2.19M | ﹤0.01% |
65,685
+20,382
| +45% | +$614K |
2023 Q4
6 quarters
|
|
2747
Vanguard Russell 2000 ETF
VTWO
$16.5B
| $2.19M | ﹤0.01% |
+25,113
| New | +$2.04M |
2025 Q2
0 quarters
|
|
2748
Employers Holdings
EIG
$882M
| $2.19M | ﹤0.01% |
46,321
+14,059
| +44% | +$678K |
2016 Q1
37 quarters
|
|
2749
Amplitude
AMPL
$1.81B
| $2.18M | ﹤0.01% |
176,084
+72,625
| +70% | +$786K |
2022 Q2
12 quarters
|
|
|
PGRE
2750
DELISTED
Paramount Group
PGRE
| $2.18M | ﹤0.01% |
356,586
-28,070
| -7% | -$146K |
2014 Q4
42 quarters
|
|
Similar funds
Barclays's Q2 2025 Portfolio in Review
As of Q2 2025, Barclays held 5,681 positions worth $436B, up 24% from $353B the previous quarter. Its ten largest holdings account for 43% of the portfolio.
Barclays's Q2 2025 filing shows 461 new, 2,914 increased, 1,345 reduced and 463 closed positions. Its largest new stake was iShares MBS ETF: 4,310,047 shares worth $405M. The largest sale was Honeywell, an estimated $1.54B.
By sector, the portfolio is most concentrated in Miscellaneous at 46% of assets, up from 41% a quarter earlier, followed by Technology and Financials.
- Barclays's largest Q2 2025 buy was iShares MBS ETF: 4,310,047 shares worth $405M.
- Barclays added most to NVIDIA in Q2 2025, an estimated $1.6B increase.
- Barclays's biggest Q2 2025 reduction was Honeywell, cutting an estimated $1.54B.
- Barclays fully exited Berry Global Group, Inc. in Q2 2025, selling an estimated $173M.
- Barclays's ten largest holdings make up 43% of its $436B portfolio in Q2 2025.
- Barclays opened 461 new positions and closed 463 in Q2 2025.
- Barclays's portfolio value rose 24% quarter-over-quarter to $436B.
Based on Barclays's 13F filing for Q2 2025, filed 13 Aug 2025.